MetLife Investment Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,958
| Closed | -$66.4K | – | 2801 |
|
|
2024
Q4 | $66.4K | Sell |
23,958
-3,991
| -14% | -$11.1K | ﹤0.01% | 2713 |
|
|
2024
Q3 | $146K | Hold |
27,949
| – | – | ﹤0.01% | 2451 |
|
|
2024
Q2 | $125K | Buy |
27,949
+8,743
| +46% | +$39K | ﹤0.01% | 2489 |
|
|
2024
Q1 | $147K | Sell |
19,206
-7,301
| -28% | -$55.9K | ﹤0.01% | 2354 |
|
|
2023
Q4 | $113K | Buy |
26,507
+8,472
| +47% | +$36.1K | ﹤0.01% | 2546 |
|
|
2023
Q3 | $75.7K | Hold |
18,035
| – | – | ﹤0.01% | 2724 |
|
|
2023
Q2 | $100K | Buy |
+18,035
| New | +$100K | ﹤0.01% | 2679 |
|